JP2017537062A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537062A5
JP2017537062A5 JP2017519672A JP2017519672A JP2017537062A5 JP 2017537062 A5 JP2017537062 A5 JP 2017537062A5 JP 2017519672 A JP2017519672 A JP 2017519672A JP 2017519672 A JP2017519672 A JP 2017519672A JP 2017537062 A5 JP2017537062 A5 JP 2017537062A5
Authority
JP
Japan
Prior art keywords
conjugate
group
protein
polyethylene glycol
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017519672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537062A (ja
JP6612860B2 (ja
Filing date
Publication date
Priority claimed from GBGB1418989.8A external-priority patent/GB201418989D0/en
Priority claimed from GBGB1418986.4A external-priority patent/GB201418986D0/en
Priority claimed from GB1418984.9A external-priority patent/GB2531715A/en
Application filed filed Critical
Priority claimed from PCT/GB2015/052953 external-priority patent/WO2016063006A1/en
Publication of JP2017537062A publication Critical patent/JP2017537062A/ja
Publication of JP2017537062A5 publication Critical patent/JP2017537062A5/ja
Application granted granted Critical
Publication of JP6612860B2 publication Critical patent/JP6612860B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017519672A 2014-10-24 2015-10-08 コンジュゲート及びコンジュゲート試薬 Active JP6612860B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1418989.8A GB201418989D0 (en) 2014-10-24 2014-10-24 Novel conjugation process and reagents
GB1418986.4 2014-10-24
GB1418984.9 2014-10-24
GB1418989.8 2014-10-24
GBGB1418986.4A GB201418986D0 (en) 2014-10-24 2014-10-24 Novel conjugates and novel conjugating reagents
GB1418984.9A GB2531715A (en) 2014-10-24 2014-10-24 Novel drug conjugates
PCT/GB2015/052953 WO2016063006A1 (en) 2014-10-24 2015-10-08 Conjugates and conjugating reagents

Publications (3)

Publication Number Publication Date
JP2017537062A JP2017537062A (ja) 2017-12-14
JP2017537062A5 true JP2017537062A5 (enExample) 2018-11-22
JP6612860B2 JP6612860B2 (ja) 2019-11-27

Family

ID=54337308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017519672A Active JP6612860B2 (ja) 2014-10-24 2015-10-08 コンジュゲート及びコンジュゲート試薬

Country Status (15)

Country Link
US (3) US20170290925A1 (enExample)
EP (1) EP3220956B1 (enExample)
JP (1) JP6612860B2 (enExample)
KR (1) KR102513926B1 (enExample)
CN (1) CN107073131B (enExample)
AU (1) AU2015334717B2 (enExample)
BR (1) BR112017005760A2 (enExample)
CA (1) CA2963043A1 (enExample)
ES (1) ES2960741T3 (enExample)
IL (1) IL250644B (enExample)
MX (1) MX2017005199A (enExample)
RU (1) RU2017108448A (enExample)
SG (1) SG11201701342XA (enExample)
WO (1) WO2016063006A1 (enExample)
ZA (1) ZA201701337B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10098960B2 (en) 2015-04-03 2018-10-16 Ucl Business Plc Polymer conjugate
JP2019506155A (ja) 2016-01-12 2019-03-07 クレッシェンド、バイオロジックス、リミテッドCrescendo Biologics Limited 治療分子
WO2017161206A1 (en) 2016-03-16 2017-09-21 Halozyme, Inc. Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
WO2017178828A1 (en) * 2016-04-14 2017-10-19 Polytherics Limited Conjugates and conjugating reagents comprising a linker that includes at least two (-ch2-ch2-0-) units in a ring
GB201608936D0 (en) * 2016-05-20 2016-07-06 Polytherics Ltd Novel conjugates and novel conjugating reagents
US11485792B2 (en) 2016-06-06 2022-11-01 Polytherics Limited Antibodies, uses thereof and conjugates thereof
GB201614162D0 (en) 2016-08-18 2016-10-05 Polytherics Ltd Antibodies, uses thereof and conjugates thereof
GB201615725D0 (en) 2016-09-15 2016-11-02 Polytherics Ltd Novel cytotoxic agents and conjugates thereof
EP3604385B1 (en) 2017-03-30 2024-05-01 NOF Corporation Heterobifunctional monodispersed polyethylene glycol and conjugate using the same
GB201711068D0 (en) 2017-07-10 2017-08-23 Crescendo Biologics Ltd Therapeutic molecules binding PSMA
US12091502B2 (en) 2018-03-13 2024-09-17 Nof Corporation Heterobifunctional compound having monodispersed polyethylene glycol in main chain and side chain
EP3789401A1 (en) 2019-09-03 2021-03-10 Gamamabs Pharma Amhrii-binding antibody drug conjugates and their use thereof in the treatment of cancers
KR20230002465A (ko) * 2020-04-29 2023-01-05 아라클론 바이오테크, 에스.엘. 질량 분석법에 의한 혈장에서의 아밀로이드 베타 펩티드의 정량화를 위한 방법
GB2594753B (en) 2020-05-27 2022-05-18 Spirea Ltd Antibody-drug conjugates
WO2023047090A1 (en) 2021-09-21 2023-03-30 Spirea Limited Antibody-drug conjugates

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US6362254B2 (en) * 1998-03-12 2002-03-26 Shearwater Corporation Poly(ethylene glycol) derivatives with proximal reactive groups
KR100511749B1 (ko) * 2001-11-06 2005-09-02 선바이오(주) 변형된 인터페론-베타, 및 이의 화학적으로 변형된 배합체
EP3434275A1 (en) * 2003-11-06 2019-01-30 Seattle Genetics, Inc. Assay for cancer cells based on the use of auristatin conjugates with antibodies
US8158590B2 (en) * 2005-08-05 2012-04-17 Syntarga B.V. Triazole-containing releasable linkers, conjugates thereof, and methods of preparation
US20070141134A1 (en) * 2005-12-16 2007-06-21 Kosak Matthew K Shielded micelles for polynucleotide delivery
EP2073820A4 (en) * 2006-09-15 2014-07-16 Belrose Pharma Inc TARGETED POLYMER PRODRUGS WITH MULTIFUNCTIONAL CONNECTORS
WO2008098930A1 (en) * 2007-02-14 2008-08-21 Biocompatibes Uk Limited Derivatisation of biological molecules
GB0922354D0 (en) * 2009-12-21 2010-02-03 Polytherics Ltd Novel polymer conjugates
ES2531471T3 (es) * 2011-02-25 2015-03-16 Lonza Ltd Enlazador ramificado para conjugados de proteínas-fármacos
CN103384534B (zh) * 2011-02-25 2015-09-30 隆萨有限公司 用于蛋白质药物偶联物的支链联接体
US9650331B2 (en) * 2012-06-18 2017-05-16 Polytherics Limited Conjugation reagents
GB201210770D0 (en) * 2012-06-18 2012-08-01 Polytherics Ltd Novel conjugation reagents
SG11201407600UA (en) 2012-06-19 2014-12-30 Polytherics Ltd Novel process for preparation of antibody conjugates and novel antibody conjugates
US20150290342A1 (en) * 2012-10-24 2015-10-15 Polytherics Limited Drug-protein conjugates
NO2789793T3 (enExample) * 2012-10-24 2018-01-27
AU2014337555C1 (en) * 2013-10-15 2021-01-28 Seagen Inc. PEGylated drug-linkers for improved Ligand-Drug Conjugate pharmacokinetics

Similar Documents

Publication Publication Date Title
RU2017108448A (ru) Конъюгаты и конъюгирующие реагенты
ES2623209T3 (es) Conjugados fármaco-proteína
CY1118994T1 (el) Πρωτεϊνες συνδεσης αντιγονου il-17 υποδοχεα α
CY1124632T1 (el) Προϊοντα συζευξης αναλογων cc-1065 και διλειτουργικοι συνδετες
ATE492290T1 (de) Saccharid-konjugatvakzine
CY1124630T1 (el) Επιλεκτικη αναγωγη αντισωματων τροποποιημενης κυστεϊνης
CY1120976T1 (el) Δις ειδικα αντισωματα igg σαν παραγοντες ενεργοποιησης τ κυτταρων
NZ754811A (en) Pyrrolobenzodiazepine-antibody conjugates
CY1116264T1 (el) Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2
CY1118880T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
UA116772C2 (uk) Виділене моноклональне антитіло або його імунологічно-активний фрагмент, що зв'язується з cd47
RU2016130933A (ru) Сульфонамид-содержащие связывающие системы для лекарственных конъюгатов
MA49158B1 (fr) Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers
BR112013000951A2 (pt) conjungados de anticorpo multifuncionais
JP2011057686A5 (enExample)
EA201001625A1 (ru) Человеческие сывороточные альбуминовые линкеры и их конъюгаты
JP2014520120A5 (enExample)
CY1115572T1 (el) Αντι cxcr4 αντισωματα και χρηση αυτων για τη θεραπεια καρκινου
EA201690862A1 (ru) Соединения для позитронно-эмиссионной томографии
JP2015523439A5 (ja) 量子ドット結合用リガンド及び組成物
CY1113121T1 (el) Υγρες συνθεσεις lh
MX2011009808A (es) Agentes de elaboracion de imagen optica.
JP2014521661A5 (enExample)
JP2017505777A5 (enExample)
NZ762865A (en) Psma-targeting amanitin conjugates